Back

Lesion metrics analysis of very high-power vs. high-power short duration radiofrequency ablation in a porcine ex vivo model.

30 March 2025 (08:00 - 15:30)
Organised by: Logo
Congress Presentation Part of: Tools and techniques in catheter ablation Catheter Ablation of Arrhythmias EHRA Premium Access EHRA 2025 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Doctor Yannick Teumer

University Hospital of Ulm, Ulm (Germany)

6 More presentations in this session

Presentation thumbnail
Curved pericardial puncture needle: a novel pericardial puncture device
Doctor Z. Jiang (Beijing, CN)
Abstract Slides Video
Presentation thumbnail
Left atrial transition voltage zone predicts arrhythmia recurrence after circumferential pulmonary vein isolation in atrial fibrillation patients with absence or mild low voltage substrate
Doctor T. Huang (Lucerne, CH)
Abstract Slides Video
Presentation thumbnail
Bipolar radiofrequency catheter ablation in the treatment of 
cardiac arrhythmias - single center experience
Doctor F. Moser (Kiel, DE)
Abstract Slides Video
Presentation thumbnail
Comparison of high-density mapping of regular atrial tachyarrhythmia between an octaspline and a pentaspline multi-electrode catheter: a randomized cross-over trial.
Doctor B. Mahmoodi (Rotterdam, NL)
Abstract Slides Video
Presentation thumbnail
Non-invasive identification of ventricular deceleration zones using electrocardiographic imaging
Mrs J. Reventos-Presmanes (Barcelona, ES)
Abstract Slides Video

Access the full session

Session thumbnail
Tools and techniques in catheter ablation
Video

The Event

Event poster

EHRA 2025

30 March - 1 April 2025
You may be interested in
thumbnail
Congress Presentation
High power short duration and very high power short duration protocol: a comparison between two effective strategies of atrial fibrillation transcatheter ablation with radiofrequency
thumbnail
Congress Presentation
Feasibility of very high-power, short-duration ablation with the QDOT Micro catheter: initial findings from the Q-POWER Study
thumbnail
Congress Presentation
Atrial fibrillation ablation with temperature-controlled very high-power short-duration, with conventional-power, or with combined modes in clinical practice: 12-month outcomes from SECURE

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources